Dosing & Uses
Anthrax Disease Prophylaxis
Pending FDA approval for treatment of post-exposure prophylaxis of disease following exposure to Bacillus anthracis in adults aged 18-65 years in conjunction with recommended antibacterial drugs
Next:
Pharmacology
Mechanism of Action
BioThrax vaccine (anthrax vaccine adsorbed) that is adjuvanted with immunostimulatory Toll-like receptor 9 (TLR9) agonist oligodeoxynucleotide CPG 7909
Active immunization with adjuvant improves immune response against Bacillus anthracis
Prepared from a cell-free filtrate of B anthracis without dead or live bacteria
Previous
Next:
Images
No images available for this drug.
Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
